Dr. Shibani Mukerji discusses how HIV affects the brain as part of a symposium at ID Week 2017.
Thomas Castles
Advertisement
Articles by Thomas Castles
The FDA has approved Gilead Sciences’ Vosevi for the treatment of adults with chronic hepatitis C virus genotypes 1-6, without cirrhosis or with mild cirrhosis.
The National Institutes of Health (NIH) is looking to determine whether Zika virus infection poses an additional risk in women whose pregnancies are already complicated by HIV.
Advertisement
Latest Updated Articles
NIH to Study Zika and HIV in Pregnant WomenPublished: July 13th 2017 | Updated:
FDA Approves Vosevi to Treat Those Infected with Chronic Hepatitis CPublished: July 18th 2017 | Updated:
How Does HIV Affect the Brain?Published: October 19th 2017 | Updated:
Advertisement
Advertisement
